Houston, Donald S <br/><br/>
Tissue factor - a therapeutic target for thrombotic disorders.  [electronic resource] 

 -  Expert opinion on therapeutic targets  Apr 2002 
 - 159-74 p.  digital 
<br/><br/> Publication Type: Journal Article; Review 
<br/><br/><label>ISSN: </label>1744-7631 
<br/><br/><label>Standard No.: </label>10.1517/14728222.6.2.159  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Angiotensin-Converting Enzyme Inhibitors--pharmacology<br/>Animals<br/>Antibodies, Monoclonal--pharmacology<br/>Arteriosclerosis--blood<br/>Blood Coagulation--drug effects<br/>Clinical Trials as Topic<br/>Cytokines--antagonists & inhibitors<br/>Drug Design<br/>Endothelium, Vascular--metabolism<br/>Enzyme Activation--drug effects<br/>Factor VIIa--antagonists & inhibitors<br/>Fibrinolytic Agents--adverse effects<br/>Glycoproteins--physiology<br/>Helminth Proteins--pharmacology<br/>Hemorrhage--chemically induced<br/>Humans<br/>Hydroxymethylglutaryl-CoA Reductase Inhibitors--pharmacology<br/>Lipoproteins--physiology<br/>Mice<br/>Monocytes--drug effects<br/>Multiprotein Complexes<br/>Neoplasms--blood<br/>Oligonucleotides, Antisense--pharmacology<br/>Prostaglandins--physiology<br/>Signal Transduction--drug effects<br/>Swine<br/>Swine, Miniature<br/>Thrombophilia--drug therapy<br/>Thromboplastin--antagonists & inhibitors<br/>Thrombosis--drug therapy